Article info

First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India

Authors

  1. Correspondence to Dr Kunchok Dorjee; kdorjee1{at}jhmi.edu
View Full Text

Citation

Tsundue T, Namdon T, Tsewang T, et al
First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India

Publication history

  • Received December 12, 2021
  • Accepted May 2, 2022
  • First published May 24, 2022.
Online issue publication 
May 24, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.